维普中文期刊产品整合服务
31篇 您的检索式:作者名="Malmstrom PU"
    题名 作者 年代 出处 被引量
1Expression of ABH blood group isoantigen as a prognostic factor in trasitional cell bladder carcinoma显示文摘Malmstrom PU Busch C Norlen BJ 1988Scand J Urol Nephrol1988,22,:1
2Recurrence, progression, and sur--ivat in bladder cancer 显示文摘MALMSTROM PU BUSCH C NORLEN BJ 1987Scand J Urol Nephrol1987,21,:1
3Early metastatic progression of bladder carcinoma: molecular profile of primary tumor and sentinel lymph node显示文摘Malmstrom PU Ren ZP Sheriff A 2002J Urol2002,168,5:1
4Alterna-ting mitomycin C and BCG instillations versus BCG alone intreatment of carcinoma in situ of the urinary bladder: a nordicstudy显示文摘Kaasinen E Wijkstrom H * Malmstrom PU 2003Eur Urol2003,43,6:1
5Advances in intravesical therapy of urinary bladder caneer显示文摘Malmstrom PU 2004Expert Rev Antieancer Ther2004,4,6:1
6Positron emission tomography in the diagnosis and staging of urinary bladder cancer显示文摘Ahlstrom H Malmstrom PU Letocha H 1996Acta Radiol1996,37,:1
7The role of Bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer显示文摘GONTERO P BOHLE A MALMSTROM PU 2010Eur Urol2010,57,3:1
8Intravesical therapy of superficial bladder cancer 显示文摘Malmstrom PU 2003Crit Rev Oncol Hematol2003,47,1:1
9Urinary fibronetin in diagnosis and follow-up of patients with urinary bladder cancer显示文摘Malmstrom PU Larsson A Johansson S 1993Br J Urol1993,72,:1
10Role ofhexaminolevulinate-guided fluorescence cystoscopy inbladder cancer: critical analysis of the latest data andEuropean guidance 显示文摘Malmstrom PU Grabe M Hang ES 2012Scand J Urol Nephrol2012,46,2:1
11Emmprin expression predicts response and survival following cisplatin containing chemothera- py for bladder cancer: A validation study 显示文摘Hemdan T Malmstrom PU Jahnson S 2015J Urel2015,194,6:1
12Labelling chemistry and characterization of-DOTA-ZHER2:342-3 Affibody molecule,a candidate agent for locoregional treatment of urinary bladder carcinoma显示文摘Fortin MA Orlova A Malmstrom PU 2007Int J Mol Med2007,19,2:1
13Recurrence, progression and survival in bladder cancer: A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up 显示文摘 Busch C Norlen BJ 1987Scand J Urol Nephrol1987,21,:1
14An individual patient data meta-analysis of the long-term outcome of randomised studies com- paring intravesical mitomycin C versus bacillus Calmette-Guerin for nonmuscle-invasive bladder cancer 显示文摘Malmstrom PU Sylvester R J Crawford DE 2009Eur Urol2009,56,5:1
15Early metastatic progression of bladder carcinoma: molecular profile of primary tumor and sentinel lymph node 显示文摘 Ren ZP sheriff A 2002J Urol2002,168,5:1
16A second-look TUR in T1 transitional cell carcinoma:why?显示文摘Jakse G Algaba F Malmstrom PU 2004Eur Urol2004,45,5:1
175-year Mlowup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma 显示文摘Malmstrom PU Wijkstrom H Lundholm C 1999J Urol1999,161,4:1
18Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction显示文摘Chestsemga C Malmstrom PU Gyllensten V 1992Cancer1992,69,5:1
19The role of bacil- lus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer显示文摘Gontero P Bohle A Malmstrom PU 2010Eur Urol2010,57,3:1
20Recurrence,progression and survival in bladder cancer:a retrospective analysis of 232 patients with greater thanorequal to 5-year follow-up显示文摘Malmstrom PU Busch C Norlen BJ 1987Scand J Urol Nephrol1987,21,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费